Clustering data with hclust algorithm for NIH WCMC Pilot & Feasibility Project: ?Metabolite changes associated with weight loss? (Study ST000257)

ESI negative ion mode ( Oxylipins analysis) (Analysis AN000406)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15
15(16)-EpODEME7018480.29NA0.240.410.390.40NA0.160.170.340.53NA0.110.318.64
15-HEPEME7018352.252.020.361.730.400.931.340.211.480.051.871.240.261.310.14
6-keto PGF1aME7018060.802.840.09NANA0.331.640.24NANA1.111.840.12NANA
12-HEPEME7018361.692.490.560.170.920.761.940.710.260.571.411.960.720.310.52
5-HETEME7018341.411.820.920.111.630.411.690.800.140.391.911.920.760.260.85
8(9)-EpETrEME701852NA2.890.11NA0.13NA1.630.15NA0.09NA3.780.16NA0.07
11(12)-EpETrEME7018510.183.580.500.040.150.142.240.450.080.110.346.520.420.150.09
14(15)-EpETrEME7018500.053.300.17NA0.090.042.150.14NA0.060.155.660.13NA0.05
TXB2ME7018050.044.180.030.030.040.025.120.060.050.090.044.460.070.040.08
5-KETEME7018450.334.130.540.060.550.153.360.490.060.110.494.280.460.120.27
11-HETEME7018310.603.980.220.040.470.134.160.180.040.060.793.720.190.050.37
PGD2ME7018080.584.450.030.030.020.084.230.040.010.000.884.570.050.030.01
PGE2ME7018070.824.580.020.100.060.583.220.050.080.032.203.030.040.140.03
12-HETEME7018300.864.260.130.110.560.412.810.170.150.711.002.780.200.170.68
15-HETEME7018291.393.200.480.080.680.393.190.340.080.101.532.790.360.100.30
12(13)-EpOMEME7018460.901.080.590.360.980.810.730.390.330.432.610.800.450.464.01
4-HDoHEME701841NANA0.070.023.47NANA0.080.032.49NANA0.090.032.72
9(10)-EpODEME7018490.37NA0.64NA2.420.67NA0.36NA0.311.18NA0.37NA2.67
13-KODEME7018420.711.580.35NA3.490.340.440.21NA0.111.160.240.17NA2.65
9-KODEME7018430.401.240.32NA3.950.290.840.17NA0.190.800.690.14NA2.98
5-HEPEME7018381.65NA1.35NA1.120.42NA1.25NA0.281.29NA1.23NA0.43
15-HETrEME7018281.93NA1.250.10NA0.94NA1.020.10NA2.19NA1.210.11NA
9,10-DiHOMEME7018140.97NA1.670.20NA0.76NA1.120.18NA2.73NA1.140.24NA
12,13-DiHOMEME7018130.38NA3.300.13NA0.32NA1.700.08NA1.47NA1.480.13NA
15,16-DiHODEME7018150.52NA2.660.29NA0.54NA1.920.22NA1.11NA1.060.43NA
14,15-DiHETrEME7018170.07NA3.050.01NA0.06NA2.520.01NA0.11NA2.980.02NA
19,20-DiHDoPAME7018230.08NA3.860.01NA0.08NA2.690.02NA0.11NA2.110.03NA
PGE1ME7018571.26NANA0.150.381.13NANA0.140.024.20NANA0.240.11
9,12,13-TriHOMEME7018111.06NA1.060.19NA0.48NA0.310.14NA5.13NA0.440.17NA
SUM-TriHOMEME7018121.06NA0.790.20NA0.52NA0.210.16NA5.54NA0.330.19NA
9-HODEME7018252.200.580.600.203.260.530.430.220.160.163.970.460.230.241.76
12(13)-Ep-9-KODEME7018550.841.340.64NA1.800.460.710.47NA0.064.040.500.38NA0.89
9(10)-EpOMEME7018471.071.040.60NA1.270.810.750.42NA0.362.831.240.40NA1.25
9-HOTEME7018271.591.420.660.402.280.471.190.310.290.252.801.540.230.411.27
9-HETEME7018322.23NA0.750.082.710.35NA0.590.100.222.47NA0.540.161.81
8-HETEME7018332.06NA0.59NA1.460.43NA0.43NA0.242.43NA0.50NA0.86
9-HEPEME7018372.75NA1.24NA1.760.12NA0.35NA0.191.69NA0.36NA0.53
14-HDoHEME7018402.68NA0.400.170.691.57NA0.460.230.613.59NA0.700.280.61
17-HDoHEME7018392.62NA0.630.131.491.36NA0.440.140.203.27NA0.760.160.80
13-HODEME7018243.170.230.890.221.921.240.200.410.190.094.700.180.380.270.90
13-HOTEME7018262.41NA0.280.121.621.44NA0.150.090.124.81NA0.130.140.69

Factors:

F1Treatment:HFD | Tissue Type:Adipose
F2Treatment:HFD | Tissue Type:Hypothalmus
F3Treatment:HFD | Tissue Type:Liver
F4Treatment:HFD | Tissue Type:Muscle
F5Treatment:HFD | Tissue Type:Plasma
F6Treatment:LFD | Tissue Type:Adipose
F7Treatment:LFD | Tissue Type:Hypothalmus
F8Treatment:LFD | Tissue Type:Liver
F9Treatment:LFD | Tissue Type:Muscle
F10Treatment:LFD | Tissue Type:Plasma
F11Treatment:SW | Tissue Type:Adipose
F12Treatment:SW | Tissue Type:Hypothalmus
F13Treatment:SW | Tissue Type:Liver
F14Treatment:SW | Tissue Type:Muscle
F15Treatment:SW | Tissue Type:Plasma
Data matrix
  logo